SEQ ID: 8 of Patent CN110662759A

General Information


DRACP ID  DRACP06069

Peptide Name   SEQ ID: 8 of Patent CN110662759A

Sequence  nKVPNLRGDLQVLAQKVART

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  αvβ6

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C92H162N30O25

Absent amino acids  CEFHIMSWY

Common amino acids  LV

Mass  242758

Pl  11.65

Basic residues  4

Acidic residues  1

Hydrophobic residues  8

Net charge  3

Boman Index  -3851

Hydrophobicity  -29.5

Aliphatic Index  112

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN110662759A

Patent Title  Tumour-Targeting Peptide Variants

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.